Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy C Rawstron

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Protocols in Cytometry|September 5, 2008
Immunophenotyping of plasma cellsAndy C Rawstron
Current Hematologic Malignancy Reports|January 12, 2013
Monoclonal B cell lymphocytosis--what does it really mean?Andy C Rawstron
Haematologica|October 13, 2005
Minimal residual disease detection in myeloma: no more molecular remissions?Andy C Rawstron
Histopathology|January 26, 2011
Occult B-cell lymphoproliferative disordersAndy C Rawstron
Hematology. American Society of Hematology. Education Program|December 17, 2009
Monoclonal B-cell lymphocytosisAndy C Rawstron
Leukemia & Lymphoma|June 20, 2007
Monoclonal B-cell lymphocytosis: good news for patients and CLL investigatorsAndy C Rawstron
Best Practice & Research. Clinical Haematology|July 13, 2010
Clinical and diagnostic implications of monoclonal B-cell lymphocytosisAndy C Rawstron, Peter Hillmen
Current Hematologic Malignancy Reports|April 29, 2010
Assessing minimal residual disease in chronic lymphocytic leukemiaAndy C Rawstron, Peter Hillmen
British Journal of Haematology|February 24, 2005
Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choiceRoger G Owen, Andy C Rawstron
British Journal of Haematology|November 21, 2007
The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemiaAndy C Rawstron, Fiona Bennett, Peter Hillmen
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Protocols in Cytometry|September 5, 2008
Immunophenotyping of plasma cellsAndy C Rawstron
Current Hematologic Malignancy Reports|January 12, 2013
Monoclonal B cell lymphocytosis--what does it really mean?Andy C Rawstron
Haematologica|October 13, 2005
Minimal residual disease detection in myeloma: no more molecular remissions?Andy C Rawstron
Histopathology|January 26, 2011
Occult B-cell lymphoproliferative disordersAndy C Rawstron
Hematology. American Society of Hematology. Education Program|December 17, 2009
Monoclonal B-cell lymphocytosisAndy C Rawstron
Leukemia & Lymphoma|June 20, 2007
Monoclonal B-cell lymphocytosis: good news for patients and CLL investigatorsAndy C Rawstron
Best Practice & Research. Clinical Haematology|July 13, 2010
Clinical and diagnostic implications of monoclonal B-cell lymphocytosisAndy C Rawstron, Peter Hillmen
Current Hematologic Malignancy Reports|April 29, 2010
Assessing minimal residual disease in chronic lymphocytic leukemiaAndy C Rawstron, Peter Hillmen
British Journal of Haematology|February 24, 2005
Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choiceRoger G Owen, Andy C Rawstron
British Journal of Haematology|November 21, 2007
The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemiaAndy C Rawstron, Fiona Bennett, Peter Hillmen
Pageof 8